학술논문
Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
Document Type
Article
Author
Source
In: Cancer Immunology, Immunotherapy . (Cancer Immunology, Immunotherapy, 1 May 2020, 69(5):771-777)
Subject
Language
English
ISSN
14320851
03407004
03407004